Skip to content

Exercise for Stable Myasthenia Gravis

Multi-modal Exercise Program for Chronic Stable Myasthenia Gravis

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01047761
Enrollment
30
Registered
2010-01-13
Start date
2010-01-31
Completion date
2020-12-31
Last updated
2016-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myasthenia Gravis

Keywords

Myasthenia Gravis, Exercise, Fitness, Body Composition, Physical Activity, Pulmonary Function, Balance

Brief summary

Generalized fatigue in myasthenia gravis results in physical deconditioning that reduces fitness and increases risk of obesity, hypertension, elevated cholesterol and type 2 diabetes. This study will examine how active and fit are 30 individuals with chronic, generalized myasthenic subjects. This study will also determine whether a 3 month home exercise program with aerobic, resistive, and pulmonary training can improve physical activity, strength, fitness, lung function and reduce cardiovascular disease risk.

Detailed description

Generalized fatigue in myasthenia gravis results in a sedentary lifestyle and profound physical deconditioning, leading to reduced fitness and increased risk of obesity, hypertension, dyslipidemia, and type 2 diabetes. This study will characterize the activity and fitness levels and cardiovascular disease risk profile in 30 chronic, generalized myasthenic subjects. Hypotheses are that a) subjects with myasthenia gravis are physically inactive with reduced fitness level and high incidence of obesity and poor cardiovascular disease risk profile, and b) a 3 month multi-modal home exercise program that includes aerobic, resistive, and pulmonary training components will improve physical activity, strength, fitness, dyspnea, body composition and reduce cardiovascular disease risk. Specific aims are to a) define the baseline physical activity and fitness levels and prevalence of insulin resistance and dyslipidemia in stable sedentary myasthenic subjects, b) determine whether a 3 month moderate intensity home exercise program is safe and feasible in deconditioned, stable myasthenic subjects and c) whether a 3 month comprehensive home exercise program can enhance fitness, strength, and lung function to improve physical activity and reduce cardiovascular disease risk.

Interventions

OTHERExercise

3 month exercise intervention, three days a week Progressive in duration - up to 1 hour daily; Progressive in intensity Multi-modal exercise program includes a) aerobic - walking, b) resistive training with therabands and core exercises, and c) breathing exercises

Sponsors

University of Maryland
CollaboratorOTHER
Baltimore VA Medical Center
Lead SponsorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* stable generalized myasthenia gravis * adults age 18-70

Exclusion criteria

* already performing regular exercise * unstable angina * recent (\<3 month) myocardial infarction, stroke, hospitalization for major illness or major surgery * chronic pain or orthopedic condition restricting exercise * active cancer, excluding basal cell cancer * anemia (HCT \<30) * pregnancy * myasthenia gravis exacerbation in past 3 months

Design outcomes

Primary

MeasureTime frame
Cardiovascular Fitness, Economy of Gait, Physiologic ReserveBaseline and 3 months

Secondary

MeasureTime frame
Ambulatory function (6 minute walk, 5 day step activity and accelerometer data)Baseline and 3 month
Myasthenia Quality of Life Scale, SF-36, and Visual Analogue Fatigue ScaleBaseline and 3 months
Cardiovascular risk profile (fasting glucose, oral glucose tolerance test, HbA1c, lipids), smoking status, and body mass indexBaseline and 3 months
Muscle strength by dynamometerBaseline and 3 month
Quantitative MG ScaleBaseline and 3 months
Pulmonary function tests - FVC and maximal inspiratory and expiratory pressureBaseline and 3 months
Body Composition by DEXA and CT of mid-thigh and hipBaseline and 3 months

Countries

United States

Contacts

Primary ContactCharlene Hafer-Macko, MD
cmacko@grecc.umaryland.edu410-328-3100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026